Arun V. Ravindran mainly investigates Psychiatry, Major depressive disorder, Mood, Evidence-based medicine and Clinical psychology. His work deals with themes such as Tolerability and Randomized controlled trial, which intersect with Psychiatry. His Major depressive disorder study combines topics in areas such as Venlafaxine and Fluoxetine.
His work carried out in the field of Mood brings together such families of science as Systematic review and Light therapy. Arun V. Ravindran has included themes like Psychotherapist, Psychodynamic psychotherapy, Cognitive behavioral therapy and Cognitive therapy in his Evidence-based medicine study. His research integrates issues of Meta-analysis and Psychological intervention in his study of Clinical psychology.
Arun V. Ravindran mostly deals with Psychiatry, Major depressive disorder, Internal medicine, Clinical psychology and Depression. The various areas that he examines in his Psychiatry study include Meta-analysis, Tolerability and Evidence-based medicine. He combines subjects such as Systematic review and Light therapy with his study of Evidence-based medicine.
His research on Major depressive disorder also deals with topics like
Depression, Psychological intervention, Major depressive disorder, Psychiatry and Internal medicine are his primary areas of study. His study in the field of Esketamine also crosses realms of Inflammatory biomarkers. His studies in Psychological intervention integrate themes in fields like Mental health and Family medicine.
His studies deal with areas such as Escitalopram, Uric acid, Cognition, Clinical psychology and Comorbidity as well as Major depressive disorder. Arun V. Ravindran combines topics linked to Meta-analysis with his work on Psychiatry. His work carried out in the field of Internal medicine brings together such families of science as Placebo and Nasal spray.
Arun V. Ravindran focuses on Depression, Psychological intervention, Major depressive disorder, Internal medicine and Anxiety. His Depression study combines topics from a wide range of disciplines, such as Iowa gambling task, Cognition and Environmental health. His Psychological intervention research is multidisciplinary, incorporating elements of Vilazodone, Desvenlafaxine, Bipolar disorder, Meta-analysis and Mental health.
The study incorporates disciplines such as Schizophrenia, Reward learning, Clinical psychology and Multivariate analysis in addition to Major depressive disorder. His Internal medicine research is multidisciplinary, incorporating perspectives in Neuroticism and Beck Depression Inventory. He has researched Anxiety in several fields, including Odds ratio, Absolute risk reduction, Incidence and Cohort study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.
Lakshmi N. Yatham;Sidney H. Kennedy;Sagar V. Parikh;Ayal Schaffer.
Bipolar Disorders (2013)
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009
Lakshmi N Yatham;Sidney H Kennedy;Ayal Schaffer;Sagar V Parikh.
Bipolar Disorders (2009)
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
Lakshmi N Yatham;Sidney H Kennedy;Sagar V Parikh;Ayal Schaffer.
Bipolar Disorders (2018)
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults
Sidney H. Kennedy;Raymond W. Lam;Sagar V. Parikh;Scott B. Patten.
Journal of Affective Disorders (2009)
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder Section 3. Pharmacological Treatments
Sidney H. Kennedy;Raymond W. Lam;Roger S. McIntyre;S. Valérie Tourjman.
The Canadian Journal of Psychiatry (2016)
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy.
Raymond W. Lam;Sidney H. Kennedy;Sophie Grigoriadis;Roger S. McIntyre.
Journal of Affective Disorders (2009)
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
Lakshmi N Yatham;Sidney H Kennedy;Claire O'Donovan;Sagar Parikh.
Bipolar Disorders (2005)
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Andrea Cipriani;Xinyu Zhou;Cinzia Del Giovane;Sarah E Hetrick.
The Lancet (2016)
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies.
Sidney H. Kennedy;Roumen Milev;Peter Giacobbe;Rajamannar Ramasubbu.
Journal of Affective Disorders (2009)
Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments.
Kennedy Sh;Lam Rw;Cohen Nl;Ravindran Av.
The Canadian Journal of Psychiatry (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University Health Network
University of British Columbia
McMaster University
University Health Network
University of British Columbia
University of Calgary
University of Toronto
Centre for Mental Health
Centre for Addiction and Mental Health
Peking University
Centre national de la recherche scientifique, CNRS
University of Paris-Saclay
Wageningen University & Research
Forschungszentrum Jülich
University of Oxford
University of North Georgia
University of Cincinnati Medical Center
Aix-Marseille University
Universidade Federal do Ceará
Royal Holloway University of London
US Forest Service
University of Naples Federico II
University of Oxford
Mayo Clinic
University of Padua
Kyushu University